Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Taek-Geun | - |
dc.contributor.author | Jang, Albert Youngwoo | - |
dc.contributor.author | Kim, Sang Wook | - |
dc.contributor.author | Hong, Young Joon | - |
dc.contributor.author | Bae, Jang-Ho | - |
dc.contributor.author | Lee, Sung Yun | - |
dc.contributor.author | Kim, Sang-Hyun | - |
dc.contributor.author | Han, Seung Hwan | - |
dc.date.available | 2020-05-18T09:36:07Z | - |
dc.date.created | 2020-05-06 | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 1745-6215 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/43545 | - |
dc.description.abstract | BACKGROUND: Despite the chronicled success of low-density lipoprotein cholesterol (LDLc)-lowering statin therapy, substantial residual cardiovascular (CV) disease risk remains a problem worldwide, highlighting the need to for combination therapies targeting non-LDLc factors, such as with fenofibrate. METHODS/DESIGN: The STAFENO trial is a prospective, randomized, open-label, multi-center trial to compare the effect of statin plus fenofibrate with statin alone on the reduction and stabilization of plaque in non-diabetic, combined dyslipidemia patients with non-intervened, intermediate coronary artery disease (CAD) using virtual histology-intravascular ultrasound at 12 months. A total of 106 eligible patients are planned to be randomized to receive either a combination therapy (rosuvastatin 10 mg plus fenofibrate 160 mg/day) or monotherapy (rosuvastatin 10 mg/day) for 12 months. The primary endpoint of this study is the percentage change in the necrotic core volume. Secondary endpoints include changes in tissue characteristics and 1-year major CV events, including all-cause mortality, CV mortality, nonfatal myocardial infarction, stroke, and revascularization of the intervened and non-intervened lesions. DISCUSSION: The STAFENO trial will address whether combination treatment of statin and fenofibrate has an additive beneficial effect compared to statin alone on the reduction and stabilization of plaque and CV events in non-diabetic, combined dyslipidemia patients with non-intervened intermediate CAD. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02232360. Registered 9 February 2014. https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0004ULE&selectaction=Edit&uid=U00023SZ&ts=2&cx=juppd2. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.relation.isPartOf | Trials | - |
dc.title | Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000530143100002 | - |
dc.identifier.doi | 10.1186/s13063-020-04291-5 | - |
dc.identifier.bibliographicCitation | Trials, v.21, no.1, pp.353 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85083947975 | - |
dc.citation.startPage | 353 | - |
dc.citation.title | Trials | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Jang, Albert Youngwoo | - |
dc.contributor.affiliatedAuthor | Han, Seung Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Combination therapy | - |
dc.subject.keywordAuthor | Fenofibrate | - |
dc.subject.keywordAuthor | Randomized control trial | - |
dc.subject.keywordAuthor | Residual cardiovascular risk | - |
dc.subject.keywordAuthor | Statin | - |
dc.subject.keywordAuthor | Virtual histology intravascular ultrasound | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.